From the RAPS website:
“The UK's National Institute for Health and Care Excellence (NICE) is launching a new office to promote market access for innovative products through early engagement with companies.
NICE says OMA's primary function will be to develop relationships with, and coordinate between, relevant government departments and the life science community. Additionally, OMA will work with companies to answer questions about market access and provide guidance on "how new and existing health technologies might be evaluated."
NICE expects the office to be operational by October 2015. NICE says it will fund about 30% of OMA using a portion of the fees gathered from the NICE scientific advice program, with about 70% of the funding coming from other grants. Eventually, NICE plans for OMA to be self-funded through fees or a subscription based service.”
